NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Intus Bio

Intus Bio

Private
Farmington, ConnecticutHealthcare & Life Scienceshttps://www.intusbio.com/

Last Round

Early Funding

Feb 14, 2018

Total Funding Raised

$1.85M

Company Overview

Intus Bio is a biotechnology company that provides an AI-powered platform, Titan-1™, for strain-level microbiome analysis and offers at-home gut health tests.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

microbiome analysisstrain-level analysisgut microbiomelong-read sequencingat-home gut testgut health testmicrobiome sequencingAI bioinformaticsmicrobiome research servicesbioinformatics platformDTC testingbiomarker discoverydrug discovery supportagricultural microbiomeenvironmental microbiome

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Intus Bio Comparables

Compare Intus Bio with similar companies based on industry and business-model similarity.

Intus Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bio-Me AS
81%
Microba Life Sciences Ltd
80%
Cmbio
77%

Intus Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 14, 2018
AcceleratorFeb 2, 2018
GrantFeb 1, 2018
SeedApr 21, 2017
Convertible DebtNov 9, 2016
Pre Seed
Mar 11, 2016

Intus Bio Investors

Notable investors and investment history

Intus Bio investors
InvestorRounds
Connecticut InnovationsSeed, Early Funding, Pre Seed
UConn Innovation FundSeed
Accelerator for Biosciences in ConnecticutAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors grew 85% MoM, from 340 to 630.

  • May 2, 2025

    Monthly visitors grew 184% MoM, reaching 1.3K.

Intus Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Intus Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Intus Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersFarmington, Connecticut
Employee Range16
Year Founded2014
Last FundingFeb 14, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.